Skip to main content
Fig. 2 | Basic and Clinical Andrology

Fig. 2

From: Clinical endocrinological evaluation of the gonadal axis (testosterone, LH and FSH) in prostate cancer patients switched from a GnRH antagonist to a LHRH agonist

Fig. 2

Mean serum LH and FSH surge in the study patients on day 2. a LH levels were significantly higher in the 1 m group than the other two groups (*; vs. 3 m group, p = 0.023; vs. 2 m group, p = 0.009; Fig. 2a). b The FSH surge was higher in the 1 m group than in the other two groups (**; vs.3 m group, p = 0.019; 2 m group, p = 0.001; Fig. 2b). Error bar shows S.D

Back to article page